HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reckitt's OTC Sales Slide 40% In 'Exceptionally Weak' Cold & Flu Season

Executive Summary

Reckitt reports major drop in OTC sales in Q1 as the cold and flu season was almost wiped out by social distancing measures related to COVID-19. CEO Laxman Narasimhan reveals he has seen green shoots in certain markets where restrictions have started to relax, insisting "there is no question flu will come back."

You may also be interested in...



RB Doubles R&D Spend In Search Of 'Game Changing’ OTC Innovation

With Reckitt's OTC sales falling 3% in 2020, the firm has committed to doubling its R&D spend in search of breakthrough product innovations.

Reckitt Reports Strongest Quarter In 20 Years Driven By 50% E-commerce Sales Jump

Consumers' significant shift to buying more health products online likely is a permanent trend, says RB CEO Laxman Narasimhan. A 37.4% jump in North America on health product stockpiling drove 13.6% growth in global health business sales.

BioGaia Sees US Investments Paying Off As Q1 Sales Rise

Sweden's BioGaia is looking to capitalize on growing momentum in the US probiotics market with a number of launches. The firm's recent US growth helped to offset falling sales in its more established European markets during the first quarter.

Topics

UsernamePublicRestriction

Register

RS151272

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel